INTERNATIONAL PATENT: SANGAMO THERAPEUTICS, INC. FILES APPLICATION FOR "SYNTHETIC TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THEREOF"

GENEVA, Nov. 12 -- SANGAMO THERAPEUTICS, INC. (501 Canal Blvd., Suite A100Richmond, California 94804) filed a patent application (PCT/US2025/027555) for "SYNTHETIC TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THEREOF" on May 02, 2025. With publication no. WO/2025/231400, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TAN, Irene (c/o Sangamo Therapeutics, Inc.501 Canal Blvd., Suite A100Richmond, California 94804), PASCHON, David (c/o Sangamo Therapeutics, Inc.501 Canal Blvd., Suite A100Richmond, California 94804)...